190 related articles for article (PubMed ID: 9265948)
1. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
Stahl S; Zivkov M; Reimitz PE; Panagides J; Hoff W
Acta Psychiatr Scand Suppl; 1997; 391():22-30. PubMed ID: 9265948
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
Montgomery SA; Reimitz PE; Zivkov M
Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
Kasper S
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():25-35. PubMed ID: 8930007
[TBL] [Abstract][Full Text] [Related]
5. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Høyberg OJ; Maragakis B; Mullin J; Norum D; Stordall E; Ekdahl P; Ose E; Moksnes KM; Sennef C
Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
8. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith WT; Glaudin V; Panagides J; Gilvary E
Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
Kasper S; Zivkov M; Roes KC; Pols AG
Eur Neuropsychopharmacol; 1997 May; 7(2):115-24. PubMed ID: 9169299
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
14. Safety of mirtazapine: a review.
Montgomery SA
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Brown MC; Nimmerrichter AA; Guest JF
Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine: clinical advantages in the treatment of depression.
Burrows GD; Kremer CM
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
[TBL] [Abstract][Full Text] [Related]
17. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled study of Org 3770 in depressed outpatients.
Claghorn JL; Lesem MD
J Affect Disord; 1995 Jun; 34(3):165-71. PubMed ID: 7560544
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
Bech P
Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
